# Effect of Anti-diabetic Drugs on Glycemic Variability

> **NCT02925559** · PHASE4 · COMPLETED · sponsor: **Centro de Diabetes Curitiba Ltda** · enrollment: 135 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Gliclazide MR

## Key facts

- **NCT ID:** NCT02925559
- **Lead sponsor:** Centro de Diabetes Curitiba Ltda
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2018-02
- **Final completion:** 2019-01
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2020-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02925559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02925559, "Effect of Anti-diabetic Drugs on Glycemic Variability". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02925559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*